APOLLO HOSPITALS ENTERPRISE LTD.

NSE : APOLLOHOSPBSE : 508869ISIN CODE : INE437A01024Industry : Hospital & Healthcare ServicesHouse : Apollo Hospitals
BSE1160.65-12.5 (-1.07 %)
PREV CLOSE ( ) 1173.15
OPEN PRICE ( ) 1173.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 92417
TODAY'S LOW / HIGH ( )1154.50 1180.00
52 WK LOW / HIGH ( )911.1 1387
NSE1162.95-9.75 (-0.83 %)
PREV CLOSE( ) 1172.70
OPEN PRICE ( ) 1177.70
BID PRICE (QTY) 1162.95 (60)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 221323
TODAY'S LOW / HIGH( ) 1154.00 1179.00
52 WK LOW / HIGH ( )910.1 1387.25
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 05-12 1979
Management Info
Prathap C Reddy - Chairman Suneeta Reddy - Managing Director
Registered Office

Address 19, Bishop Gardens,Raja Annamalaipuram, ,
Chennai,
Tamil Nadu-600028

Phone 044 - 28290956 / 28293896

Email investor.relations@apollohospitals.com

Website www.apollohospitals.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
10May Apollo Hospitals launches ‘Department
Apollo Hospitals Enterprise has launched their ‘Department of Women &..
10May Apollo Hospitals strengthens on launch
Apollo Hospitals Enterprise is currently trading at Rs. 1184.05, up by 1..
01Apr Apollo Hospitals Enterprise informs ab
Apollo Hospitals Enterprise has informed about details of loss of certif..
09Mar Apollo Hospitals Enterprise informs ab
Apollo Hospitals Enterprise has informed about payment of interestThe ab..
25Feb Apollo Hospitals opens 330-bed super s
Apollo Hospitals Enterprise has opened a new 330-bed super speciality ho..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit869.32332
Gross Profit 1304 3301.3
Operating Profit 2759.78423
Net Sales 21690.471830.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Narayana Hrudayalay (BSE)
 191.00 (2.80%)
M.Cap (Rs. in Cr)3903.29
Aster DM Healthcare (BSE)
 132.30 (2.40%)
M.Cap (Rs. in Cr)6684.16
Tejnaksh Healthcare (BSE)
 53.90 (2.18%)
M.Cap (Rs. in Cr)54.75
Medinova Diagnostic (BSE)
 14.80 (4.96%)
M.Cap (Rs. in Cr)14.77
DhanvantriJeevan Rek (BSE)
 11.57 (4.99%)
M.Cap (Rs. in Cr)4.74
Shareholding Pattern
PROMOTERS 34.4%
NON-INSTITUTION 8.11%
MUTUAL FUNDS/UTI 7.1%
FI/BANKS/INSURANCE 5.72%
GOVERNMENT 0.23%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.